VIVA BIOTECH (01873) spent 802,500 Hong Kong dollars to repurchase 600,000 shares on May 27th.
Viva Biotech Holdings (01873) announces that on May 27, 2026, the company spent HK$802,500 to repurchase 600,000 shares at a repurchase price of HK$1.33-1.34 per share.
VIVA BIOTECH (01873) announced on May 27, 2026 that the company spent 802,500 Hong Kong dollars to repurchase 600,000 shares at a repurchase price of 1.33-1.34 Hong Kong dollars per share.
Related Articles
Pharmaron Beijing (03759) plans to build a project in Shaoxing that would produce 200 tons of pharmaceutical intermediates and APIs annually.
CONSUN PHARMA (01681) plans to carry out a share buyback program.
Pharmaron Beijing (03759) plans to invest approximately 2 billion yuan to establish a new drug commercial production and CDMO research and development production service base in Qiantang District, Hangzhou City.
Pharmaron Beijing (03759) plans to build a project in Shaoxing that would produce 200 tons of pharmaceutical intermediates and APIs annually.
CONSUN PHARMA (01681) plans to carry out a share buyback program.
Pharmaron Beijing (03759) plans to invest approximately 2 billion yuan to establish a new drug commercial production and CDMO research and development production service base in Qiantang District, Hangzhou City.
